Newswise — LEXINGTON, Ky. (July 30, 2020) —The COVID-19 pandemic brought many things to a screeching halt and continues to impact our daily lives. However, important research at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) is continuing under extreme caution and deep dedication.
“It can’t wait,” said Dr. Greg Jicha, a neurologist at SBCoA.
A monumental study in the field of dementia research is set to get underway in the coming weeks at UK. Researchers will be looking at a medication that recently received experimental approval from The United States Food and Drug Administration and its impact on the newly characterized form of dementia known as LATE. The disease was named and popularized about one year ago by an international working group led by Dr. Peter Nelson, the senior neuropathologist at SBCoA.
LATE is a disease with…
